With supply chain issues, product release schedules, and the timeliness of contamination investigations, the need for a rapid sterility testing solution is greater than ever before.
A substitute test method for USP Chapter <71>, ARL Bio Pharma’s rapid sterility testing enables short incubation times when compared to traditional sterility testing. While 14 to 18 days is the typical incubation time for USP <71>, rapid sterility testing can produce results within only 6 days of incubation.
These shortened incubation times are possible due to Charles River’s Celsis® rapid microbial detection system, which allows for the processing of multiple sample types. Additionally, species-level identification can be completed in the event of a non-sterile test result since it does not need another filtration step of the test media.
ARL Bio Pharma provides analytical and microbiological testing for the pharmaceutical industry. ARL has been serving the clinical and pharmaceutical markets since 1998.
In addition to working as a CNA for the past 13 years, Lucie has broad experience in communications, editing, writing, public relations and research, both in the private sector and for non-profits. For the last several years, she has actively worked as a communications, marketing and PR consultant for numerous clients, most notably CVS Health, Towers Watson, Mars Inc, ReadyTech, Ancestry, Aartrijk, Wildflower Health, Communication Partners Inc, ExpertBeacon, Liberty Global, Acrobatiq and Words & Numbers.
This post is related to:
Quality Control, Lab Testing Services
